Investors

Stock Info
OTCQBWIZP
News
Jan 21, 2020

Wize Pharma, Inc. (OTCQB: WIZP) ("Wize"), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed enrolment in its Phase IV...

Jan 16, 2020

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has entered into a strategic transaction with...

Dec 3, 2019

Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it amended the terms of certain convertible loans which...

More News

SEC Filings
0001218683
Investor Presentation
Planned Move Into Non-Viral Gene Therapy

Subscribe For Alerts
* Required Fields